Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/37217
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorALVES, Cresio
dc.contributor.authorFRANCO, Ruth Rocha
dc.date.accessioned2020-08-20T13:28:52Z-
dc.date.available2020-08-20T13:28:52Z-
dc.date.issued2020
dc.identifier.citationARCHIVES OF ENDOCRINOLOGY METABOLISM, v.64, n.3, p.223-234, 2020
dc.identifier.issn2359-3997
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/37217-
dc.description.abstractPrader-Willi syndrome (PWS) is a genetic disorder caused by the absence of gene expression in the 15q11.2-q13 paternal chromosome. Patients with PWS develop hypothalamic dysfunction that can lead to various endocrine changes such as: obesity, growth hormone deficiency, hypogonadism, hypothyroidism, adrenal insufficiency and low bone mineral density. In addition, individuals with PWS have increased risk of developing type 2 diabetes mellitus. This review summarizes and updates the current knowledge about the prevention, diagnosis and treatment of endocrine manifestations associated with Prader Willi syndrome, especially diagnosis of growth hormone deficiency, management and monitoring of adverse effects; diagnosis of central adrenal insufficiency and management in stressful situations; screening for central hypothyroidism; research and treatment of hypogonadism; prevention and treatment of disorders of glucose metabolism. Careful attention to the endocrine aspects of PWS contributes significantly to the health of these individuals.eng
dc.language.isoeng
dc.publisherSBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIAeng
dc.relation.ispartofArchives of Endocrinology Metabolism
dc.rightsopenAccesseng
dc.subjectPrader-Willi syndromeeng
dc.subjectgrowth hormoneeng
dc.subjecthypogonadismeng
dc.subjecthypothyroidismeng
dc.subjectadrenal insufficiencyeng
dc.subjectglucose abnormalitieseng
dc.subject.othergrowth-hormone treatmenteng
dc.subject.otherbone-mineral densityeng
dc.subject.otherpsychiatric-treatmenteng
dc.subject.otherenergy-expenditureeng
dc.subject.othermotor developmenteng
dc.subject.otherbody-compositioneng
dc.subject.otheryoung-childreneng
dc.subject.othergh deficiencyeng
dc.subject.otherpeptide yyeng
dc.subject.otherobesityeng
dc.titlePrader-Willi syndrome: endocrine manifestations and managementeng
dc.typearticleeng
dc.rights.holderCopyright SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIAeng
dc.identifier.doi10.20945/2359-3997000000248
dc.identifier.pmid32555988
dc.subject.wosEndocrinology & Metabolismeng
dc.type.categoryrevieweng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalALVES, Cresio:Univ Fed Bahia UFBA, Hosp Univ Prof Edgard Santos, Fac Med, Unidade Endocrinol Pediat, Salvador, BA, Brazil
hcfmusp.description.beginpage223
hcfmusp.description.endpage234
hcfmusp.description.issue3
hcfmusp.description.volume64
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000541630700006
hcfmusp.origem.id2-s2.0-85086434497
hcfmusp.origem.idSCIELO:S2359-39972020000300223
hcfmusp.publisher.cityRIO DE JANEIRO, RJeng
hcfmusp.publisher.countryBRAZILeng
hcfmusp.relation.referenceAkefeldt A, 1999, DEV MED CHILD NEUROL, V41, P789, DOI 10.1017/S0012162299221573eng
hcfmusp.relation.referenceAllas S, 2013, ENDOCR DEV, V25, P157, DOI 10.1159/000346065eng
hcfmusp.relation.referenceAngulo MA, 2015, J ENDOCRINOL INVEST, V38, P1249, DOI 10.1007/s40618-015-0312-9eng
hcfmusp.relation.referenceArenz T, 2010, J PEDIATR ENDOCR MET, V23, P867, DOI 10.1515/jpem.2010.140eng
hcfmusp.relation.referenceBakker NE, 2015, J CLIN ENDOCR METAB, V100, P1609, DOI 10.1210/jc.2014-4347eng
hcfmusp.relation.referenceBakker NE, 2017, J CLIN ENDOCR METAB, V102, P1702, DOI 10.1210/jc.2016-2962eng
hcfmusp.relation.referenceBalikcioglu PG, 2015, J CLIN ENDOCR METAB, V100, P3822, DOI 10.1210/jc.2015-2503eng
hcfmusp.relation.referenceBedogni G, 2014, OBESITY FACTS, V7, P71, DOI 10.1159/000358570eng
hcfmusp.relation.referenceBizzarri C, 2010, EUR J ENDOCRINOL, V162, P499, DOI 10.1530/EJE-09-1033eng
hcfmusp.relation.referenceBrambilla P, 2011, NUTR METAB CARDIOVAS, V21, P269, DOI 10.1016/j.numecd.2009.10.004eng
hcfmusp.relation.referenceBurman P, 2001, ENDOCR REV, V22, P787, DOI 10.1210/er.22.6.787eng
hcfmusp.relation.referenceBurnett LC, 2017, J CLIN INVEST, V127, P293, DOI 10.1172/JCI88648eng
hcfmusp.relation.referenceButler JV, 2002, DEV MED CHILD NEUROL, V44, P248, DOI 10.1017/S001216220100202Xeng
hcfmusp.relation.referenceButler MG, 2016, PROG MOL BIOL TRANSL, V140, P1, DOI 10.1016/bs.pmbts.2015.12.003eng
hcfmusp.relation.referenceButler MG, 2008, AM J MED GENET A, V146A, P854, DOI 10.1002/ajmg.a.32249eng
hcfmusp.relation.referenceButler MG, 2007, AM J MED GENET A, V143A, P449, DOI 10.1002/ajmg.a.31507eng
hcfmusp.relation.referenceButler MG, 2006, NAT CLIN PRACT ENDOC, V2, P592, DOI 10.1038/ncpendmet0320eng
hcfmusp.relation.referenceButler MG, 2019, CURR PEDIATR REV, V15, P207, DOI 10.2174/1573396315666190716120925eng
hcfmusp.relation.referenceButler MG, 2019, AM J MED GENET A, V179, P1826, DOI 10.1002/ajmg.a.61293eng
hcfmusp.relation.referenceButler MG, 2019, J MED GENET, V56, P149, DOI 10.1136/jmedgenet-2018-105301eng
hcfmusp.relation.referenceButler MG, 2017, PRENATAL DIAG, V37, P81, DOI 10.1002/pd.4914eng
hcfmusp.relation.referenceButler MG, 2011, CURR GENOMICS, V12, P204, DOI 10.2174/138920211795677877eng
hcfmusp.relation.referenceButler MG, 2009, J ASSIST REPROD GEN, V26, P461, DOI 10.1007/s10815-009-9341-7eng
hcfmusp.relation.referenceCai Dongsheng, 2013, Drug Discov Today Dis Mech, V10, pe63eng
hcfmusp.relation.referenceCarel JC, 2012, J CLIN ENDOCR METAB, V97, P416, DOI 10.1210/jc.2011-1995eng
hcfmusp.relation.referenceCarrel AL, 2002, J CLIN ENDOCR METAB, V87, P1581, DOI 10.1210/jc.87.4.1581eng
hcfmusp.relation.referenceCassidy SB, 1997, AM J MED GENET, V68, P433eng
hcfmusp.relation.referenceCassidy SB, 2012, GENET MED, V14, P10, DOI 10.1038/gim.0b013e31822bead0eng
hcfmusp.relation.referenceCastner DM, 2014, RES DEV DISABIL, V35, P3081, DOI 10.1016/j.ridd.2014.07.035eng
hcfmusp.relation.referenceChen KY, 2015, J CLIN ENDOCR METAB, V100, P1639, DOI 10.1210/jc.2014-4024eng
hcfmusp.relation.referenceCohen M, 2015, CLIN ENDOCRINOL, V83, P212, DOI 10.1111/cen.12694eng
hcfmusp.relation.referenceColmenares A, 2011, HORM RES PAEDIAT, V75, P123, DOI 10.1159/000319709eng
hcfmusp.relation.referenceCrino A, 2003, EUR J PEDIATR, V162, P327, DOI 10.1007/s00431-002-1132-4eng
hcfmusp.relation.referenceDeal CL, 2013, J CLIN ENDOCR METAB, V98, pE1072, DOI 10.1210/jc.2012-3888eng
hcfmusp.relation.referenceDi Giorgio G, 2014, HORM RES PAEDIAT, V81, P189, DOI 10.1159/000356927eng
hcfmusp.relation.referenceDimitropoulos A, 2008, J AUTISM DEV DISORD, V38, P1642, DOI 10.1007/s10803-008-0546-xeng
hcfmusp.relation.referenceEldar-Geva T, 2010, EUR J ENDOCRINOL, V162, P377, DOI 10.1530/EJE-09-0901eng
hcfmusp.relation.referenceEmerick Jill E, 2013, Int J Pediatr Endocrinol, V2013, P14, DOI 10.1186/1687-9856-2013-14eng
hcfmusp.relation.referenceEspadaler J, 2017, CNS SPECTRUMS, V22, P315, DOI 10.1017/S1092852915000711eng
hcfmusp.relation.referenceFarholt S, 2011, J CLIN ENDOCR METAB, V96, pE173, DOI 10.1210/jc.2010-0782eng
hcfmusp.relation.referenceFeigerlova E, 2008, J CLIN ENDOCR METAB, V93, P2800, DOI 10.1210/jc.2007-2138eng
hcfmusp.relation.referenceFeigerlova E, 2010, J CLIN ENDOCR METAB, V95, P4600, DOI 10.1210/jc.2009-1831eng
hcfmusp.relation.referenceFesten DAM, 2008, CLIN ENDOCRINOL, V68, P919, DOI 10.1111/j.1365-2265.2007.03126.xeng
hcfmusp.relation.referenceFesten DAM, 2007, CLIN ENDOCRINOL, V67, P449, DOI 10.1111/j.1365-2265.2007.02910.xeng
hcfmusp.relation.referenceFintini D, 2016, NUTR METAB CARDIOVAS, V26, P842, DOI 10.1016/j.numecd.2016.05.010eng
hcfmusp.relation.referenceFintini D, 2016, PEDIATR OBES, V11, P235, DOI 10.1111/ijpo.12052eng
hcfmusp.relation.referenceFintini D, 2014, DIABETES CARE, V37, pE76, DOI 10.2337/dc13-2575eng
hcfmusp.relation.referenceGagnon J, 2015, DIABETES, V64, P1513, DOI 10.2337/db14-1176eng
hcfmusp.relation.referenceGoldstone AP, 2012, INT J OBESITY, V36, P1564, DOI 10.1038/ijo.2011.274eng
hcfmusp.relation.referenceGoldstone AP, 2008, J CLIN ENDOCR METAB, V93, P4183, DOI 10.1210/jc.2008-0649eng
hcfmusp.relation.referenceGrugni G, 2016, BEST PRACT RES CL EN, V30, P785, DOI 10.1016/j.beem.2016.11.003eng
hcfmusp.relation.referenceGrugni G, 2011, J PEDIATR ENDOCR MET, V24, P477, DOI 10.1515/JPEM.2011.269eng
hcfmusp.relation.referenceHaqq AM, 2011, J CLIN ENDOCR METAB, V96, pE225, DOI 10.1210/jc.2010-1733eng
hcfmusp.relation.referenceHokken-Koelega A, 2016, ENDOCR CONNECT, V5, pR44, DOI 10.1530/EC-16-0028eng
hcfmusp.relation.referenceHolsen LM, 2012, INT J OBESITY, V36, P638, DOI 10.1038/ijo.2011.204eng
hcfmusp.relation.referenceJin Dong-Kyu, 2012, Korean J Pediatr, V55, P224, DOI 10.3345/kjp.2012.55.7.224eng
hcfmusp.relation.referenceJohnson L, 2016, AM J MED GENET A, V170, P594, DOI 10.1002/ajmg.a.37488eng
hcfmusp.relation.referenceKhan MJ, 2018, PEDIATR OBES, V13, P3, DOI 10.1111/ijpo.12177eng
hcfmusp.relation.referenceKim Y, 2019, TRANSL RES, V208, P105, DOI 10.1016/j.trsl.2019.02.012eng
hcfmusp.relation.referenceLEE PDK, 1987, AM J MED GENET, V28, P865, DOI 10.1002/ajmg.1320280411eng
hcfmusp.relation.referenceMaejima Y, 2011, AGING-US, V3, P1169, DOI 10.18632/aging.100408eng
hcfmusp.relation.referenceManzardo AM, 2018, GENET MED, V20, P24, DOI 10.1038/gim.2017.92eng
hcfmusp.relation.referenceMcCandless SE, 2011, PEDIATRICS, V127, P195, DOI 10.1542/peds.2010-2820eng
hcfmusp.relation.referenceMiller JL, 2014, J PEDIATR ENDOCR MET, V27, P23, DOI 10.1515/jpem-2013-0116eng
hcfmusp.relation.referenceMiller JL, 2012, J CLIN ENDOCR METAB, V97, P3837, DOI 10.1210/jc.2012-2543eng
hcfmusp.relation.referenceMuscogiuri G, 2019, REV ENDOCR METAB DIS, V20, P239, DOI 10.1007/s11154-019-09502-2eng
hcfmusp.relation.referenceMyers SE, 2007, AM J MED GENET A, V143A, P443, DOI 10.1002/ajmg.a.31468eng
hcfmusp.relation.referenceNishi Y, 2017, PEDIATR ENDOCR REV P, V14, P235, DOI 10.17458/per.vol14.2017.nt.growthhormonetreatmenteng
hcfmusp.relation.referenceObrynba KS, 2018, J PEDIATR ENDOCR MET, V31, P809, DOI 10.1515/jpem-2017-0487eng
hcfmusp.relation.referencePaepegaey AC, 2018, ENDOCR CONNECT, V7, P663, DOI 10.1530/EC-18-0089eng
hcfmusp.relation.referenceRoof E, 2000, J INTELL DISABIL RES, V44, P25, DOI 10.1046/j.1365-2788.2000.00250.xeng
hcfmusp.relation.referenceSalvatoni A, 2019, AM J MED GENET A, V179, P2067, DOI 10.1002/ajmg.a.61304eng
hcfmusp.relation.referenceSchulze A, 2001, ACTA PAEDIATR, V90, P455, DOI 10.1080/080352501750126474eng
hcfmusp.relation.referenceSedky K, 2014, J CLIN SLEEP MED, V10, P403, DOI 10.5664/jcsm.3616eng
hcfmusp.relation.referenceSeetho IW, 2011, DIABETES RES CLIN PR, V92, pE1, DOI 10.1016/j.diabres.2010.12.009eng
hcfmusp.relation.referenceSharkia M, 2013, J PEDIATR-US, V163, P800, DOI 10.1016/j.jpeds.2013.03.058eng
hcfmusp.relation.referenceSiemensma EPC, 2011, CLIN ENDOCRINOL, V75, P83, DOI 10.1111/j.1365-2265.2011.03989.xeng
hcfmusp.relation.referenceSingh P, 2018, PEDIATRICS, V142, DOI 10.1542/peds.142.1_MeetingAbstract.230eng
hcfmusp.relation.referenceSmith T, 2015, INT J MOL SCI, V16, P4416, DOI 10.3390/ijms16034416eng
hcfmusp.relation.referenceSode-Carlsen R, 2010, GROWTH HORM IGF RES, V20, P179, DOI 10.1016/j.ghir.2009.12.004eng
hcfmusp.relation.referenceStanic D, 2017, PSYCHONEUROENDOCRINO, V80, P137, DOI 10.1016/j.psyneuen.2017.03.011eng
hcfmusp.relation.referenceSze L, 2011, J CLIN ENDOCR METAB, V96, pE1314, DOI 10.1210/jc.2011-0038eng
hcfmusp.relation.referenceTauber M, 2007, HORM RES, V68, P48, DOI 10.1159/000110475eng
hcfmusp.relation.referenceTauber M, 2016, PEDIATR ENDOCR REV P, V14, P138, DOI 10.17458/PER.2016.TDM.SequelaeofGHeng
hcfmusp.relation.referenceVaiani E, 2010, CLIN ENDOCRINOL, V73, P546, DOI 10.1111/j.1365-2265.2010.03840.xeng
hcfmusp.relation.referencevan Wijngaarden RFAD, 2008, J CLIN ENDOCR METAB, V93, P1649, DOI 10.1210/jc.2007-2294eng
hcfmusp.relation.referencevan Wijngaarden RFAD, 2009, J CLIN ENDOCR METAB, V94, P4205, DOI 10.1210/jc.2009-0454eng
hcfmusp.relation.referenceVestergaard P, 2004, J PEDIATR-US, V144, P614, DOI 10.1016/j.jpeds.2004.01.056eng
hcfmusp.relation.referenceWhitman B, 2004, J PEDIATR ENDOCR MET, V17, P591eng
hcfmusp.relation.referenceWhittington JE, 2007, EUR J HUM GENET, V15, P127, DOI 10.1038/sj.ejhg.5201716eng
hcfmusp.relation.referenceZhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255eng
dc.description.indexMEDLINEeng
dc.identifier.eissn2359-4292
hcfmusp.citation.scopus7-
hcfmusp.scopus.lastupdate2022-04-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HC/ICr
Instituto da Criança - HC/ICr

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_ALVES_PraderWilli_syndrome_endocrine_manifestations_and_management_2020.PDFpublishedVersion (English)180.8 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.